Back to Trades
Lawler John
Chief Development OfficerCIK 0002123720
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Lawler John, Chief Development Officer, has filed 1 SEC report (2026), all concentrated in Chemomab Therapeutics Ltd. (CMMB), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Apr 10 | CMMB Chemomab Therapeutics Ltd. | Lawler John | Chief Development Officer | Other | $0 |
1 filing